Qurient
Internet Service Providers, Website Hosting & Internet-related Services · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
242 C-dong Fl 8, Seongnam, Gyeonggi-do, ...Phone Number
+82 3180601600Website
www.qurient.comRevenue
<$5 MillionIndustry
About Qurient
Qurient Org Chart
Is Qurient your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Qurient, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Qurient had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Qurient recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Qurient
Funding: Get notified immidiatlly once Qurient has new funding data
Check out if Qurient is spiking on competitors!
Product Launch: Get notified when Qurient launches new products
Website visits: Recent activity has been detected on your website
Check if Qurient has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Qurient
Find 3 more new buyers
Company Profile Activity
Activity Insights
Qurient is experiencing very low activity levels compared to other companies in the Telecommunications sector.
What does this means?
Qurient is drawing exceptional interest within the Telecommunications industry, suggesting notable developments or strong market momentum, learn more about Qurient.
Qurient Tech Stack
A closer look at the technologies used by Qurient
Qurient News & Media
Lonza's Synaffix Collaborates with Qurient Therapeutics to Enable Development of Dual-Payload ADC
License agreement centered around technology enabling dual-payload ADC Unique combination of Synaffix's exatecan-based technology with Qurient's CDK7 inhibitor AMSTERDAM and SEONGNAM-SI, South Korea , Sept. 25, 2025 /PRNewswire/ -- Synaffix B.V. ("Synaffix"), a Lonza company (SWX:LONN)...Qurient Launches Clinical Trial for Acute Myeloid Leukemia Treatment with Adrixetinib (Q702)
SEONGNAM, South Korea--(BUSINESS WIRE)-- #Qurient--Qurient Launches Clinical Trial for Acute Myeloid Leukemia Treatment with Adrixetinib (Q702)Qurient Therapeutics Enters CRADA with the National Cancer Institute to Collaborate on a Phase 1/2 Clinical Study of Q901 in Combination with TROP2-ADC
SEONGNAM-SI, South Korea--(BUSINESS WIRE)-- #Qurient--Qurient Co. Ltd. (KRX: 115180), a clinical-stage biotech company based in Korea, entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to evaluate Qurient’s proprietary CDK7 inhibitor, Q901, in combination with an antibody drug conjugate (ADC) targeting tumor-associated calcium signal transducer 2 (TROP2) with topoisomerase 1 inhibiQurient Co. Ltd. and TB Alliance Announce Exclusive License Agreement for Telacebec (Q203), a New Anti-Tuberculosis Agent
Landmark Agreement for New Tuberculosis Treatment SEONGNAM-SI, South Korea and NEW YORK, Feb. 3, 2023 /PRNewswire/ -- Qurient Co. Ltd. ("Qurient", KRX: 115180), a clinical-stage biotechnology company based in South Korea, and TB Alliance, a not-for-profit organization dedicated to the...
Top Internet Service Providers, Website Hosting & Internet-related Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Qurient
Gabia offers a range of services including domain registration, cloud solutions, IDC, hosting, email, and groupware. Their products are designed for businesses and individuals looking to establish an online presence. The company provides support for website management and security features. Gabia aims to assist clients in navigating the complexitie... Read More